These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2483203)

  • 1. [Evaluation of the functional state of the complement and fibrinolysis systems].
    Tiutrin II; Smol'ianinov ES; Udut VV; Vasil'ev NV; Tsisik RM
    Lab Delo; 1989; (12):43-5. PubMed ID: 2483203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of blood coagulating and fibrinolytic activity of tumor on the state of systemic hemostasis in patients with stomach cancer].
    Zyrianov BN; Karpov AB; Udut VV; Tsisik RM; Tikhonov VI; Tiutrin II
    Vopr Onkol; 1990; 36(11):1316-21. PubMed ID: 2281636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction.
    Sundsmo JS; Fair DS
    Clin Physiol Biochem; 1983; 1(2-5):225-84. PubMed ID: 6241121
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis and complement-system profiles during aorto-femoral bypass implantation].
    Wüst HJ; Fiedler HW; Trobisch H; Richter O
    Anaesthesist; 1982 Oct; 31(10):564-74. PubMed ID: 6185014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk evaluation of thromboembolic diseases according to functional test data in patients with advanced malignancies.
    Zyryanov BN; Tutrin II; Udut VV
    Neoplasma; 1987; 34(3):353-60. PubMed ID: 3614469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of the hemostatic system in patients with disseminated stomach cancer].
    Tiutrin II; Karpov AB; Udut VV; Tsisik RM; Solokhina EA
    Vopr Onkol; 1989; 35(4):460-5. PubMed ID: 2728389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW; Tønder O; Matre R
    Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolytic system of plasma in peripheral and gastric blood in peptic ulcer and gastric carcinoma].
    Puchalski Z; Prokopowicz J; Gabryelewicz A
    Pol Przegl Chir; 1976 Mar; 48(3):369-73. PubMed ID: 1264868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolysis in cancer].
    Abe T; Inoue H; Imagawa U; Obuchi S
    Gan No Rinsho; 1969 Sep; 15(9):785-96. PubMed ID: 5391404
    [No Abstract]   [Full Text] [Related]  

  • 12. [State of the anticoagulant system in patients with cancer as an indication of the reactivity of the organism].
    Gorodilova VV; Bergut FA; Saraeva ZM
    Vopr Onkol; 1968; 14(9):28-31. PubMed ID: 5686834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indices of the activity of blood anticoagulation system in cancer patients at different hydrogen-ion concentration].
    Andreenko GV; Bergut FA; Levite EM
    Lab Delo; 1971; 6():351-4. PubMed ID: 4108750
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clotting-fibrinolytic system and complements (author's transl)].
    Kondo M
    Rinsho Byori; 1978; 26(4):277-81. PubMed ID: 671772
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic values of serum type III procollagen N-terminal peptide in type IV gastric cancer].
    Akazawa S; Fujiki T; Kanda Y; Kumai R; Yoshida S
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):861-6. PubMed ID: 3985646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines.
    Kinjo M; Oka K; Naito S; Kohga S; Tanaka K; Oboshi S; Hayata Y; Yasumoto K
    Br J Cancer; 1979 Jan; 39(1):15-23. PubMed ID: 758928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune reactivity and fibrinolysis in patients with disseminated pulmonary tuberculosis].
    Sverdlova MV
    Probl Tuberk; 1993; (1):41-3. PubMed ID: 8327438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.